Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does KRAS Codon 13 Mutation Have Prognostic Value in Colorectal Cancer?

NCT05657210 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT05657210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05657210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does KRAS Codon 13 Mutation Have Prognostic Value in Colorectal Cancer?
Lead sponsor
Seoul National University Bundang Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2009
Completion date
December 31, 2021
Enrollment
2,203 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer